"Welcome to our company blog. Within these blog posts, we hope to share our insights on clinical quality management, the patient-centered medical home, chronic disease management in primary care, evidence-based medicine, and the use of technology in ambulatory care settings."

- David Morin, CEO and Donald Nease Jr., MD, Chief Medical Officer

We are proud to announce that we have been awarded a $1.3 million Phase II STTR  from the National Cancer Institute to develop and prototype a next-generation clinical quality management system. This award is a follow-on to our previous Phase I project. In the Phase I we studied and documented what technology primary care practices and providers need for disease management and quality improvement. In this Phase II project, we will be developing and prototyping a system that meets these needs. As was the case in Phase I, we are teaming with the University of Michigan Health System Department of Family Medicine on the project. We are also very proud of the perfect score we received on the grant. We think this is a testament to the need of our work. We'll be working with lots of great people on this and involving many in the healthcare community. We look forward to showing you what we come up with with! For more information on the grant, click here. Dave Morin Co-Founder and CEO Cielo MedSolutions